Since hypermethylation at the promoter region of tumor suppressor genes, e.g., RARB2, TFPI2, RASSF1A, MGMT, and PTEN, helped to distinguish melanoma patients from healthy individuals [48], epigenetic changes in cfDNA may also serve as diagnostic markers in melanoma [49]. The gene discussed is MGMT; the disease is melanoma.